Literature DB >> 17038280

Thromboembolic disease after foot and ankle surgery.

Sarah S Hanslow1, Les Grujic, Henry K Slater, Darren Chen.   

Abstract

BACKGROUND: The incidence and potential life-threatening complications of thromboembolic disease after major orthopaedic surgery has been extensively studied. However, there are two studies pertaining to the incidence of thromboembolic disease after foot and ankle surgery, the findings of which suggest that the incidence is too low to justify routine thromboprophylaxis.
METHODS: This is a retrospective study identifying the incidence of thromboembolic disease after foot and ankle surgery in the practices of two foot and ankle specialists. The purpose of the study was to evaluate the risk factors for the development of thromboembolic disease and to examine the issue of routine thromboprophylaxis. Six hundred and two patients were included in this study.
RESULTS: There was a 4% incidence (24 patients) of postoperative thromboembolic complications. Risk factors identified for postoperative thromboembolic disease were a history of rheumatoid arthritis, a recent history of air travel, previous deep vein thrombosis or pulmonary embolism, and limb immobilization.
CONCLUSIONS: The incidence of thromboembolic disease after foot and ankle surgery could be higher than that previously reported particularly if a patient has certain risk factors. Prospective randomized clinical trials are needed to establish the true incidence of thromboembolic disease after foot and ankle surgery and to define the indications for routine thromboprophylaxis.

Entities:  

Mesh:

Year:  2006        PMID: 17038280     DOI: 10.1177/107110070602700907

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  8 in total

1.  Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.

Authors:  Abdullah Pandor; Daniel Horner; Sarah Davis; Steve Goodacre; John W Stevens; Mark Clowes; Beverley J Hunt; Tim Nokes; Jonathan Keenan; Kerstin de Wit
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

2.  Morbidity and readmission after open reduction and internal fixation of ankle fractures are associated with preoperative patient characteristics.

Authors:  Bryce A Basques; Christopher P Miller; Nicholas S Golinvaux; Daniel D Bohl; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2014-10-22       Impact factor: 4.176

3.  Incidence of deep vein thrombosis and pulmonary embolism after Achilles tendon rupture.

Authors:  Arush Patel; Brent Ogawa; Timothy Charlton; David Thordarson
Journal:  Clin Orthop Relat Res       Date:  2011-11-02       Impact factor: 4.176

4.  Detection of Pulmonary Embolism in the Postoperative Orthopedic Patient Using Spiral CT Scans.

Authors:  Han Jo Kim; Sarah Walcott-Sapp; Kristi Leggett; Anne Bass; Ronald S Adler; Helene Pavlov; Geoffrey H Westrich
Journal:  HSS J       Date:  2009-09-23

5.  The safety of foot and ankle procedures at an ambulatory surgery center.

Authors:  Peter Adamson; Wesley Peters; Cory Janney; Vinod Panchbhavi
Journal:  J Orthop       Date:  2020-03-28

Review 6.  Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery.

Authors:  James D F Calder; Richard Freeman; Erica Domeij-Arverud; C Niek van Dijk; Paul W Ackermann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-03-18       Impact factor: 4.342

7.  Individual risk factors predictive of venous thromboembolism in patients with temporary lower limb immobilization due to injury: a systematic review.

Authors:  Daniel Horner; Abdullah Pandor; Steve Goodacre; Mark Clowes; Beverley J Hunt
Journal:  J Thromb Haemost       Date:  2019-02-07       Impact factor: 5.824

8.  Prophylaxis of Venous Thromboembolism in Ankle and Foot Surgeries.

Authors:  Roberto Zambelli; Marcos de Bastos; Suely Meireles Rezende
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2020-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.